Roystone Capital Management’s Elevance Health ELV Stock Holding History

Roystone Capital Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-87,000	Closed	-$19.1M	–	34
2018 Q1	$19.1M	Buy	+87,000	New	+$20.4M	1.71%	23
2017 Q3	–	Sell	-86,100	Closed	-$16.2M	–	39
2017 Q2	$16.2M	Sell	86,100 -212,000	-71%	-$38.1M	1.08%	33
2017 Q1	$49.3M	Sell	298,100 -564,500	-65%	-$89.8M	3.19%	12
2016 Q4	$124M	Buy	862,600 +265,150	+44%	+$35.5M	7.33%	1
2016 Q3	$74.9M	Buy	597,450 +110,500	+23%	+$14.3M	4.55%	6
2016 Q2	$64M	Buy	+486,950	New	+$66.6M	4.03%	12
2016 Q1	–	Sell	-314,000	Closed	-$43.8M	–	30
2015 Q4	$43.8M	Sell	314,000 -359,000	-53%	-$49.5M	2.41%	17
2015 Q3	$94.2M	Buy	+673,000	New	+$101M	4.5%	10
2015 Q2	–	Sell	-199,000	Closed	-$30.7M	–	37
2015 Q1	$30.7M	Sell	199,000 -218,500	-52%	-$31.1M	1.14%	27
2014 Q4	$52.5M	Buy	417,500 +2,500	+0.6%	+$309K	2.08%	25
2014 Q3	$49.6M	Buy	+415,000	New	+$47.6M	2.03%	25

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Roystone Capital Management's ELV Position: Q2 2018 in Review

Roystone Capital Management sold out of Elevance Health (ELV) in Q2 2018, closing a stake of 87,000 shares — an estimated $19.1M sold.

Roystone Capital Management first reported a position in ELV in Q3 2014 and held it in 11 quarters. The position peaked at $124M in Q4 2016. 935 funds tracked by Wall St. Rank hold ELV as of Q2 2018.

Roystone Capital Management reported no remaining Elevance Health position as of Q2 2018 after selling out during the quarter.
Roystone Capital Management sold 87,000 Elevance Health shares in Q2 2018, an estimated $19.1M.
Roystone Capital Management first reported a position in Elevance Health in Q3 2014 and held it in 11 quarters.
Roystone Capital Management's Elevance Health position peaked at $124M in Q4 2016.
935 funds tracked by Wall St. Rank held Elevance Health as of Q2 2018.

Based on Roystone Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.